🟢 Fennec Pharmaceuticals is trading 6.85% up in pre-market with no company-specific announcement identified

Fennec Pharmaceuticals is trading 6.85% up at $13.11 after rising from the August 28 close of $12.27; the pre-market move remains unexplained.

• No company-specific announcement dated August 31, 2026, was identified in the available search.
• The latest confirmed company release remains the August 11 second-quarter report.
• That report showed $17.1 million in net product sales and $2.8 million in adjusted EBITDA.